BioPharma Resources

Drugs by condition

Drugs approved for sarcoma

Brand-name prescription drugs and biologics whose FDA label lists sarcoma as an approved use. Matched on the label phrases: "sarcoma".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

9

Still marketed, NDA or BLA

Drug classes

4

Novel drugs

4

New molecular entities and new biologics

In development

28

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for sarcoma.

  • Oxderys (Doxorubicin Hydrochloride) · Avyxa Holdings Nov 9, 2026
  • Tecentriq Hybreza (Atezolizumab and Hyaluronidase-Tqjs) · Genentech INC Sep 12, 2024
  • Tecentriq (Atezolizumab) · Genentech INC NovelBreakthrough therapyAccelerated approvalPriority reviewOrphanMay 18, 2016
  • Pomalyst (Pomalidomide) · Bristol NovelBreakthrough therapyAccelerated approvalPriority reviewOrphanFeb 8, 2013
  • Votrient (Pazopanib Hydrochloride) · Novartis NovelOrphanOct 19, 2009

All approved drugs for sarcoma, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 38 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Programmed Death Receptor-1 Blocking Antibody (2)

Thalidomide Analog (1)

  • Pomalyst Pomalidomide · Bristol · 2013

Retinoid (1)

  • Panretin Alitretinoin · Advanz Pharma · 1999

Class not listed in FDA's data (5)

Drugs in development for sarcoma

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • HS-20093Ris-Rez, Risvutatug rezetecanPhase 316 trials

    Hansoh BioMedical R&D Company · Neoplasms, Lung, Sarcoma, Osteosarcoma

  • Anlotinib hydrochlorideAL3818, CatequentenibPhase 312 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Alveolar Soft Part Sarcoma, Metastatic Colorectal Cancer, Endometrial Neoplasms

  • L19TNFL19IL2, OnfekafuspPhase 310 trials

    Philogen S.p.A. · Glioblastoma, Locally Advanced Basal Cell Carcinoma, Melanoma Stage III

  • MK-2140Zilovertamab Vedotin, VLS-101Phase 39 trials

    Merck & Co. · Diffuse Large B-Cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, B-cell Acute Lymphoblastic Leukemia

  • AL8326Phase 34 trials

    Advenchen Pharmaceuticals, LLC. · Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms

  • ChiauranibCS2164Phase 33 trials

    Chipscreen Biosciences, Ltd. · Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Soft Tissue Sarcoma

  • KC1036Phase 33 trials

    Beijing Konruns Pharmaceutical Co., Ltd. · Ewing Sarcoma, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma (ESCC)

  • 1.0% IP-001IP-001Phase 32 trials

    Immunophotonics, Inc. · Colorectal Cancer (CRC), Colon Cancer Liver Metastases, Rectal Cancer

  • INT230-6Phase 31 trial

    Intensity Therapeutics, Inc. · Sarcoma,Soft Tissue

  • TBI-1301Phase 31 trial

    Takara Bio Inc. · Synovial Sarcomas

  • BenmelstobartPhase 24 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Alveolar Soft Part Sarcoma, Non-Small Cell Lung Cancer, Gastroesophageal Adenocarcinoma

  • T3011Phase 24 trials

    Shanghai Pharmaceuticals Holding Co., Ltd · Advanced Solid Tumors, Nonmuscle-invasive Bladder Cancer, Solid Tumor

  • ADCAntibody-drug conjugate, ADCE-D01Phase 23 trials

    MBrace Therapeutics · Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer, Colo-rectal Cancer

  • Recombinant Human IL1215-PDL1B Oncolytic HSV-1, VG161Phase 23 trials

    CNBG-Virogin Biotech (Shanghai) Ltd. · Advanced Malignant Solid Tumor, Sarcoma, Advanced Intrahepatic Cholangiocarcinoma

  • AL58805Phase 22 trials

    Advenchen Pharmaceuticals, LLC. · Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms

  • CAB-AXL-ADCBA3011Phase 22 trials

    BioAtla, Inc. · Non-Small-Cell Lung Cancer, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma

  • Checkpoint InhibitorPhase 22 trials

    EpicentRx, Inc. · Solid Tumor, Adult, Cancer, Neoplasms

  • GI-102Phase 22 trials

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS)

  • HH2853Phase 22 trials

    Haihe Biopharma Co., Ltd. · Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL), FL Lymphoma, Epithelioid Sarcoma

  • Tigilanol TiglateEBC-46Phase 22 trials

    QBiotics Group Limited · Soft Tissue Sarcoma, Head and Neck Cancer

1 discontinued brand-name drugs whose label still names it

More on sarcoma: recruiting trials · published research

Related in oncology: Breast cancer · Non-small cell lung cancer · Small cell lung cancer · Prostate cancer · Colorectal cancer · Melanoma · Ovarian cancer · Pancreatic cancer · Bladder and urothelial cancer · Kidney cancer (renal cell carcinoma)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.